|
IQCC expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.641600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.382500E-02 |
| Normal-vs-Stage2 |
3.674600E-01 |
| Normal-vs-Stage3 |
1.738590E-01 |
| Normal-vs-Stage4 |
6.716000E-01 |
| Stage1-vs-Stage2 |
5.635400E-01 |
| Stage1-vs-Stage3 |
2.810300E-04 |
| Stage1-vs-Stage4 |
2.682000E-02 |
| Stage2-vs-Stage3 |
5.916300E-02 |
| Stage2-vs-Stage4 |
3.436000E-01 |
| Stage3-vs-Stage4 |
5.295400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.809700E-02 |
| Normal-vs-AfricanAmerican |
8.619800E-02 |
| Normal-vs-Asian |
9.818400E-03 |
| Caucasian-vs-AfricanAmerican |
8.018800E-01 |
| Caucasian-vs-Asian |
1.617840E-04 |
| AfricanAmerican-vs-Asian |
9.59910000000175E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.972400E-02 |
| Normal-vs-Female |
3.986800E-01 |
| Male-vs-Female |
2.597400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.632000E-01 |
| Normal-vs-Extreme_Weight |
6.220300E-02 |
| Normal-vs-Obese |
1.886980E-01 |
| Normal-vs-Extreme_Obese |
4.367600E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.323800E-01 |
| Normal_Weight-vs-Obese |
6.774600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.764600E-01 |
| Extreme_Weight-vs-Obese |
6.565200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.904800E-01 |
| Obese-vs-Extreme_Obese |
7.895000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.396000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.592400E-02 |
| Normal-vs-Age(61-80Yrs) |
1.046820E-01 |
| Normal-vs-Age(81-100Yrs) |
2.433800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.571000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.728200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.891050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.681000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.941500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.083900E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.761100E-04 |
| Normal-VS-Type2 PRCC |
1.464390E-02 |
| Normal-VS-KIRP CIMP |
7.818800E-03 |
| Normal-VS-Unclassified PRCC |
5.686800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
1.62503344114384E-12 |
| Type1 PRCC-VS-KIRP CIMP |
1.13969999993024E-07 |
| Type1 PRCC-VS-Unclassified PRCC |
1.106090E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.232500E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
7.319600E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
3.203000E-04 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.993000E-01 |
| Normal-vs-N1 |
5.368800E-01 |
| Normal-vs-N2 |
4.077900E-02 |
| N0-vs-N1 |
6.519400E-01 |
| N0-vs-N2 |
3.658600E-01 |
| N1-vs-N2 |
3.871800E-01 |
|
|
